Iopamiro

Iopamidol, the active ingredient in Iopamiro, is an iodinated contrast media presented as a solution for injection for intra‑arterial and intravenous use. It provides radiographic contrast enhancement for angiography and computed tomography (CT) scans in patients undergoing diagnostic imaging procedures.

GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to stringent quality standards and provides reliable global distribution to meet clinical demand. Products are manufactured under EU regulations and are available in multiple vial sizes to suit various imaging protocols.

Iopamiro is an iodinated contrast agent used in radiographic imaging to improve visualization of vascular and tissue structures. - Angiography: Provides enhanced visualization of blood vessels during intra‑arterial imaging procedures. - Computed Tomography (CT) scans: Improves contrast of anatomical structures, aiding diagnosis in CT imaging.

Iopamiro may be associated with a range of adverse reactions, ranging from mild and transient to potentially serious.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Metallic or bitter taste in the mouth. - Mild nausea or vomiting. - Headache or mild dizziness. - Transient itching or urticaria. - Injection site pain or discomfort.

Serious or Rare Side Effects: - Severe allergic reactions, including anaphylaxis. - Acute hypotension or cardiovascular collapse. - Contrast‑induced nephropathy leading to renal impairment. - Seizures or neurologic disturbances. - Cardiac arrhythmias. - Pulmonary edema or respiratory distress.

Prior to administration, clinicians should evaluate patient-specific risk factors and monitor for adverse events. - Assess renal function: check serum creatinine and eGFR before use. - Review allergy history: avoid in patients with known iodine or contrast media hypersensitivity. - Use the lowest effective dose to achieve diagnostic quality. - Monitor vital signs during and after injection, especially in high‑risk patients. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Iopamiro can interact with certain medications, necessitating careful management to reduce risk.

Major Interactions (Avoid): - Metformin: discontinue before and after contrast exposure to prevent lactic acidosis. - NSAIDs: avoid concurrent use due to increased risk of renal toxicity. - Aminoglycoside antibiotics: avoid as they may potentiate nephrotoxic effects. - Diuretics: use with caution; may exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - ACE inhibitors: monitor renal function and consider temporary suspension. - Beta‑blockers: may mask hypotensive responses. - Thyroid hormone preparations: monitor thyroid function as iodine load can affect hormone levels.